Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Nov-2017IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancerPalmieri, C; Szydlo, R; Miller, M; Barker, L; Patel, NH, et al
18-Sep-2017Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Saleem, A; Searle, GE; Kenny, LM; Huiban, M; Kozlowski, K, et al
24-Mar-2017Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancerYague, E; Asaduzzaman, M; Constantinou, S; Haoxiang, M; Gallon, J, et al
8-Sep-2017Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Saleem, A; Searle, GE; Kenny, LM; Huiban, M; Kozlowski, K, et al
3-May-2017Long-Term Follow-Up of the Intergroup Exemestane StudyMorden, JP; Alvarez, I; Bertelli, G; Coates, AS; Coleman, R, et al
16-Aug-2017p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsPeriyasamy, M; Singh, A; Gemma, C; Kranjec, C; Farzan, R, et al
13-Jun-2017IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsPalmieri, C; Stein, RC; Liu, X; Hudson, E; Nicholas, H, et al
24-Nov-2017Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIESCheang, MCU; Bliss, JM; Viale, G; Speirs, V; Palmieri, C, et al